Real World Evidence (RWE) Solutions Market Research 2020 by Industry Growth, Business Opportunities, Top Manufacture, Industry Share Report, Status, Regional Outlook and Global Forecast to 2026
Market Research Engine has published a new report titled as “Real World Evidence (RWE) Solutions Market Size by Component (Services, Data Sets, Clinical setting data, Claims data, Pharmacy data and Patient powered data), By Therapeutic area (Oncology, Cardiovascular, Neurology, Immunology and Others), By End Users (Pharmaceutical and Medical Devices Companies, Healthcare Providers, Healthcare Payers and Other End Users), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2021-2027.”
The Real World Evidence (RWE) Solutions Market is expected to be around US$ 3.13 Billion by 2027 at a CAGR of 14% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/real-world-evidence-solutions-market
The real world evidence solutions market is projected to rise majorly during the forecast period with the support from regulatory agencies for the utilization of RWE solutions. Using traditional pharmacovigilance methods and latest digital aids, regulators deploy real world evidence to monitor the safety of marketed drugs. Legislators are also beginning to realize the prominence of real world evidence. It further stimulates the patient-centered medication research and has enhanced the design and review of clinical trials. As a result of these changes, the global real world evidence solutions market is growing. In addition to this, the market growth is anticipated to be fueled by drug development delays resulting in a subsequent increase in development costs.
The global Real World Evidence (RWE) Solutions market is segregated on the basis of Component as Services, Data Sets, Clinical setting data, Claims data, Pharmacy data and Patient powered data. Based on Therapeutic area the global Real World Evidence (RWE) Solutions market is segmented in Oncology, Cardiovascular, Neurology, Immunology and Others. Based on End Users the global Real World Evidence (RWE) Solutions market is segmented in Pharmaceutical and Medical Devices Companies, Healthcare Providers, Healthcare Payers and Other End Users.
The global Real World Evidence (RWE) Solutions market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Real World Evidence (RWE) Solutions market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Anthem Inc., Clinigen Group plc, Cognizant Technology Solutions Corporation, IBM Corporation, ICON plc, IQVIA, Optum, Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., PPD Inc., SAS Institute Inc., Syneos Health Inc., Pharmaceutical Product Development, LLC, Medpace Holdings, and others are among the major players in the global Real World Evidence (RWE) Solutions market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Real World Evidence (RWE) Solutions Market has been segmented as below:
Real World Evidence (RWE) Solutions Market, By Component • Services • Data Sets • Clinical setting data • Claims data • Pharmacy data • Patient powered data
Real World Evidence (RWE) Solutions Market, By Therapeutic area • Oncology • Cardiovascular • Neurology • Immunology • Others
Real World Evidence (RWE) Solutions Market, By End Users • Pharmaceutical and Medical Devices Companies • Healthcare Providers • Healthcare Payers • Other End Users
Real World Evidence (RWE) Solutions Market, By Region • North America • Europe • Asia-Pacific • Rest of the World
Real World Evidence (RWE) Solutions Market, By Company • Anthem Inc. • Clinigen Group plc • Cognizant Technology Solutions Corporation • IBM Corporation • ICON plc • IQVIA • Optum • Oracle Corporation • PAREXEL International Corporation • PerkinElmer Inc. • PPD Inc. • SAS Institute Inc. • Syneos Health Inc. • Pharmaceutical Product Development, LLC • Medpace Holdings
The report covers:
• Global Real World Evidence (RWE) Solutions market sizes from 2021 to 2027, along with CAGR for 2021-2026 • Market size comparison for 2021 vs 2027, with actual data for 2021, estimates for 2020 and forecast from 2021 to 2027 • Global Real World Evidence (RWE) Solutions market trends, covering comprehensive range of consumer trends & manufacturer trends • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Real World Evidence (RWE) Solutions market • Major market opportunities and challenges in forecast timeframe to be focused • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management • Comprehensive company profiles of the key industry players
Report Scope:
The global Real World Evidence (RWE) Solutions market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Real World Evidence (RWE) Solutions market share. Major industry players with significant revenue share include Anthem Inc., Clinigen Group plc, Cognizant Technology Solutions Corporation, IBM Corporation, ICON plc, IQVIA, Optum, Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., PPD Inc., SAS Institute Inc., Syneos Health Inc., Pharmaceutical Product Development, LLC, Medpace Holdings, and others.
Reasons to Buy this Report:
• Gain detailed insights on the Real World Evidence (RWE) Solutions industry trends • Find complete analysis on the market status • Identify the Real World Evidence (RWE) Solutions market opportunities and growth segments • Analyse competitive dynamics by evaluating business segments & product portfolios • Facilitate strategy planning and industry dynamics to enhance decision making Customization Customized report as per the requirement can be offered with appropriate recommendations
Request Sample Report from here: https://www.marketresearchengine.com/real-world-evidence-solutions-market
Table of Contents:
- Introduction 1.1. Key Points 1.2. Report Description 1.3. Markets Covered 1.4. Stakeholders
- Research Methodology
- Executive Summary
- Market Overview
- Real World Evidence (RWE) Solutions Market, By Component
- Real World Evidence (RWE) Solutions Market, By Therapeutic area
- Real World Evidence (RWE) Solutions Market, By End Users
- Real World Evidence (RWE) Solutions Market, By Geography
- Competitive Insights
- Company Profiles
10.1. Anthem Inc.
10.2. Clinigen Group plc
10.3. Cognizant Technology Solutions Corporation
10.4. IBM Corporation
10.5. ICON plc
10.6. IQVIA
10.7. Optum
10.8. Oracle Corporation 10.9. PAREXEL International Corporation 10.10. PerkinElmer Inc. 10.11. PPD Inc. 10.12. SAS Institute Inc. 10.13. Syneos Health Inc. 10.14. Pharmaceutical Product Development, LLC 10.15. Medpace Holdings
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States